Silencing or pharmacological inhibition of FSP1 elevates lipid ROS, reactivates GSK3β-dependent Snail degradation, restores E-cadherin, and markedly suppresses CRC-cell migration [30]. The gene discussed is AIFM2; the disease is colorectal carcinoma.